Prostate cancer affects one in eight men in the U.S. over their lifetime, which is the same rate as women and breast cancer.
Cancer-free after stage 3 diagnosis: Washington man shares recovery journey and Seahawks-fueled hope
A Washington Seahawks fan shares his inspiring journey to becoming cancer-free after a stage 3 prostate cancer diagnosis.
Vic McCarty, a longtime Northern Michigan broadcaster and former sports anchor at UpNorthLive News, has died. He passed away peacefully April 6, 2026, at Munson ...
Biomarker testing has the potential to streamline diagnosis, treatment planning, and anticipation of treatment risks, if done right.
Patients with up to 20 brain metastases demonstrated significantly improved daily and neurocognitive functioning with ...
Morning Overview on MSN
Metformin may mimic exercise-linked metabolite in prostate cancer patients
Prostate cancer patients treated with the widely prescribed diabetes drug metformin showed elevated blood levels of N-lactoyl ...
A health check event led to 36 individuals requiring further investigation. The Royal Arch Freemasons of Hertfordshire and their families attended the PSA prostate health check, which aims to raise ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides a market update on its commercial and operational performance ...
Detailed price information for Medicus Pharma Ltd (MDCX-Q) from The Globe and Mail including charting and trades.
Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs ...
Morning Overview on MSN
Michigan Medicine identifies new drug target for GI neuroendocrine tumors
Researchers at Michigan Medicine report a potential new therapeutic target for gastrointestinal neuroendocrine tumors: a ...
BRAINTREE council leader Graham Butland has marked the second year of living with prostate cancer and is urging others to get checked.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results